Papers

9

Total Citations

492

H-Index

8

About

Ronald M. van Dam is a leading figure in the field of minimally invasive pancreatic and liver surgery, with a career dedicated to rigorously evaluating and advancing surgical techniques through high-impact clinical trials and nationwide implementation studies. His major contributions center on proving the superiority of minimally invasive approaches over traditional open surgery. His landmark DIPLOMA trial (280 citations) provided crucial evidence comparing oncological outcomes in distal pancreatectomy for ductal adenocarcinoma, while the LEOPARD trial (55 citations) established the cost-effectiveness and quality-of-life benefits of the minimally invasive approach. Dr. van Dam has been instrumental in the adoption of robotic surgery, from early work on the da Vinci system for cholecystectomy (56 citations) to recent nationwide analyses of robotic liver and pancreatic resections. He has led pan-European surveys on the implementation of robotic and laparoscopic liver surgery, and his work on nationwide outcomes—tracking over 1,000 robotic pancreatoduodenectomies—has defined the learning curve and safety of these complex procedures. With a career spanning from pioneering feasibility studies to large-scale, real-world data, Dr. van Dam’s research has directly shaped modern surgical practice, improving recovery and outcomes for patients across Europe.

Research Focus

Key Achievements

8
H-Index
9
Papers
492
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA)
280 citations · 2017
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 161
🏛 Institutions: Amsterdam UMC Location University of Amsterdam, Maastricht University, Maastricht University Medical Centre

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago